Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 6,259

Document Document Title
WO/2018/007217A1
The present invention relates to novel sulfonamide derivatives, to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants, ...  
WO/2018/009256A1
The present invention relates to ampakines, including low impact ampakines, and pharmaceutical compositions and methods employing ampakines for treating central nervous system (CNS) disorders, including attention deficit disorders. Novel...  
WO/2018/004289A2
The present invention relates to a benzoxazine-based mixture and a use thereof and, more specifically, to a benzoxazine-based mixture and a use of a cured product in which the benzoxazine-based mixture is cured, wherein the benzoxazine-b...  
WO/2018/004066A1
The present invention relates to an aryl ethane derivative, for inhibiting an estrogen-related receptor gamma (ERRγ) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, an...  
WO/2018/004065A1
The present invention relates to an aryl ethane derivative, for inhibiting an estrogen-related receptor gamma (ERRγ) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, an...  
WO/2017/216299A1
The object of the present invention are compounds comprising at least one donor group and at least one acceptor group, as described herein, which are characterized by a pronounced CT character. The invention also relates to the use there...  
WO/2017/215549A1
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...  
WO/2017/205425A1
Described herein are molecules for use in organic light emitting diodes comprising at least one moiety A, at least one moiety D, and at least one moiety B.  
WO/2017/205880A1
Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomer synthesis while maintaining overall yield and purity of a synthesi...  
WO/2017/196805A1
The present disclosure provides a curable system containing a benzoxazine and a benzothiazole sulfenamide. The curable system may be catalyzed at temperatures generally used to cure multifunctional epoxy resins yet exhibits improved pot-...  
WO/2017/184604A1
In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured, or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2017/179661A1
According to the present invention, a charge transport polymer which contains a structural unit having an N-aryl phenoxazine skeleton is configured and is used as a charge transport material.  
WO/2017/157322A1
Provided are a compound represented by formula I, a raceme thereof, an R-isomer thereof, an S-isomer thereof, a pharmaceutical salt thereof, and a mixture thereof, a preparation method therefor, a pharmaceutical composition comprising th...  
WO/2017/155102A1
Provided is a compound which comprises 2 or more donor groups having different structures and a linking group that links these donor groups, wherein the linking group is an aromatic group constituted from 1 or more benzene rings optional...  
WO/2017/155686A1
An acyclic fluorinated compound of formula (I) is amine -containing acyclic hydrofluoroethers. The acyclic fluorinated compound is useful as heat transfer, solvent cleaning, fire extinguishing agents and electrolyte solvents and additives.  
WO/2017/129069A1
The present invention falls within the field of chemical pharmaceutical techniques, and in particular provides the preparation of a tetrahydroquinoline-related bicyclic compound and use thereof, wherein the compound has the structure as ...  
WO/2017/125093A1
Disclosed are a hydroquinone compound, a preparation method therefor, and an application in tumour resistance or immunomodulation. The structural formula of the hydroquinone compound is as shown in formula I, wherein: X is C=O or CH2; Y ...  
WO/2017/122209A2
Disclosed herein are compounds capable of inhibiting dimerization of NF-κB, for example, p65-p65 homodimerization and/or p50-p65 heterodimerization, the compounds being represented by formula I: X-L2-L1-L'2-Y Formula I wherein X, Y, L1,...  
WO/2017/114052A1
Disclosed are a high stress resistant plant growth regulator and a preparation method and use thereof. In particular, the compound provided by the present invention is an ABA substitute for significantly improving the stress resistance o...  
WO/2017/116558A1
The present invention relates to compounds that inhibit LSD1 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and ...  
WO/2017/108152A1
The present invention relates to compounds according to formula (I), which are suitable for use in electronic devices, preferably organic electroluminescent devices.  
WO/2017/109095A1
The invention relates to (hetero) cyclic compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.  
WO/2017/102063A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2017/104294A1
The purpose of the present invention is to provide an oxazine compound that is characterized by having a group that has an aromatic ring structure and multiple specified carbon-carbon double bond structures. Further, a composition includ...  
WO/2017/104295A1
The purpose of the present invention is to provide an oxazine compound that is characterized by having a group that has an aromatic ring structure and multiple specified carbon-carbon double bond structures. Further, a composition includ...  
WO/2017/098927A1
The present invention provides an oxazine compound having a specific structure, which is characterized by including a group having: an aromatic ring structure; and a plurality of specified carbon-carbon triple bond structures. The presen...  
WO/2017/093157A1
The present invention relates to compounds of formula I or pharmaceutically acceptable salt, solvate or hydrate thereof wherein ASC is Ring A represents a 4- to 6-membered saturated ring containing carbon atoms as ring members in additio...  
WO/2017/095732A1
Described herein is an unsaturated fluorinated compound of formula (I) where X is O or N; Y is F or H; Z is F or CF3; and A is F or CF3 wherein when X is O, then n is 1, Y is H, Z is F, A is F, and Rf is a linear or branched perfluorinat...  
WO/2017/070796A1
The present application relates to novel heterocycle derivatives of Formula (I), to processes for preparing them, pharmaceutical compositions containing them, and their use thereof in the treatment or prevention of acute and/or chronic n...  
WO/2017/070718A4
The invention provides compounds for use as medicaments, which act by inhibiting CYP17A1 and CYP19A1 enzymes. The compounds have particular application in the treatment of cancer especially prostate cancer and breast cancer. The compound...  
WO/2017/070719A3
The invention provides pharmacophores for use in the design, screening and identification of inhibitors of CYP17A1 and CYP19A1 enzymes. A preferred pharmacophore has a spatial arrangement of atoms as shown in the accompanying Figure 1, w...  
WO/2017/070718A1
The invention provides compounds for use as medicaments, which act by inhibiting CYP17A1 and CYP19A1 enzymes. The compounds have particular application in the treatment of cancer especially prostate cancer and breast cancer. The compound...  
WO/2017/066699A1
The invention includes methods and materials for forming and manipulating aromatic-based polymers and copolymers using biomass compounds as starting materials. Embodiments of the invention can be used in processes designed to replace tho...  
WO/2017/064350A1
The invention relates to a new family of six-membered benzo-heterocycles having oxygen and nitrogen atoms, joined to substituted purines, halogens and triazoles which are useful in cancer treatment, in particular in treatments whose ther...  
WO/2017/056115A1
The present invention provides novel N-aryl containing fused heterocyclic compounds as anticancer agents, especially as estrogen receptor (ER) antagonists/ degraders and process for their preparation.  
WO/2017/049409A1
Disclosed are compounds of general formula (I) that promote readthrough of a premature termination codon (PTC) of an RNA molecule in a translation system, and their use, alone or in combination with other compounds, such as aminoglycosid...  
WO/2017/049245A2
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions fu...  
WO/2017/049245A3
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions fu...  
WO/2017/040965A1
A lubricant composition includes a base oil present in an amount of greater than 70 parts by weight per 100 parts by weight of the lubricant composition and an antioxidant. The antioxidant has the structure: wherein each X is independent...  
WO/2017/040963A1
The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2', L, X, W, Y1,Y2, Y3, and Y4 are described herein.  
WO/2017/028940A1
The present invention relates to the compounds of the formula (1) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material or dopant in the emitting layer and/or a...  
WO/2017/028941A1
The present invention relates to the compounds of the formulae (1) and (2) and to organic electroluminescent devices, in particular blue- emitting devices, in which these compounds are used as host material or dopant in the emitting laye...  
WO/2017/024229A8
A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium...  
WO/2017/024229A1
A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium...  
WO/2017/018476A1
Provided is a crystal of a quinazoline derivative. The present invention relates to an acid addition salt of a compound represented by formula (I), and a pharmaceutical composition and the like which contain the acid addition salt.  
WO/2017/018751A1
The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, comprising same as an active ingredient. I...  
WO/2017/017505A1
Invention is related to novel compounds – benzenesulfonamides of general formulas (I) and (II). The compounds can be used in biomedicine as active ingredients in pharmaceutical formulations, because they inhibit enzymes which participa...  
WO/2017/018750A1
The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, comprising same as an active ingredient. I...  
WO/2017/014546A1
The present invention relates to a luminescent material for delayed fluorescence and an organic electroluminescent device comprising the same. By using the luminescent material for delayed fluorescence according to the present invention,...  
WO/2017/012890A1
The present invention relates to novel selective 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and the use thereof to prevent age-induced skin structure and function defects.  

Matches 1 - 50 out of 6,259